Natriuretic Peptides in Chronic Heart Failure

Normal brain natriuretic peptide (BNP) and N-terminal proBNP (NT-proBNP) levels are helpful in excluding chronic heart failure in the ambulatory setting, although they have been studied less well and possibly less accurately than in acute care. They may also be of help in screening patients at risk...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Hans-Peter Brunner-La Rocca, Sandra Sanders-van Wijk
Formato:	article
Lenguaje:	EN
Publicado:	Radcliffe Medical Media 2019
Materias:	Diseases of the circulatory (Cardiovascular) system RC666-701
Acceso en línea:	https://doaj.org/article/57768560db9c46f5a594691b34c910ef
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:57768560db9c46f5a594691b34c910ef
record_format	dspace
spelling	oai:doaj.org-article:57768560db9c46f5a594691b34c910ef2021-12-04T16:00:49ZNatriuretic Peptides in Chronic Heart Failure10.15420/cfr.2018.26.12057-75592057-7540https://doaj.org/article/57768560db9c46f5a594691b34c910ef2019-01-01T00:00:00Zhttps://www.cfrjournal.com/articles/natriuretic-peptides-chronic-heart-failurehttps://doaj.org/toc/2057-7540https://doaj.org/toc/2057-7559Normal brain natriuretic peptide (BNP) and N-terminal proBNP (NT-proBNP) levels are helpful in excluding chronic heart failure in the ambulatory setting, although they have been studied less well and possibly less accurately than in acute care. They may also be of help in screening patients at risk to intervene and reduce the development of heart failure. Natriuretic peptides are also excellent prognostic markers of chronic heart failure, but the clinical value of such prognostic information is less clear. One possible application for this information is guiding medical therapy in chronic heart failure. Many studies have investigated this approach, but results are mixed and do not clearly show improvement in outcome. Still, it may be that in patients with reduced ejection fraction and few comorbidities, measuring NT-proBNP to uptitrate medication improves prognosis.Hans-Peter Brunner-La RoccaSandra Sanders-van WijkRadcliffe Medical MediaarticleDiseases of the circulatory (Cardiovascular) systemRC666-701ENCardiac Failure Review , Vol 5, Iss 1, Pp 44-49 (2019)
institution	DOAJ
collection	DOAJ
language	EN
topic	Diseases of the circulatory (Cardiovascular) system RC666-701
spellingShingle	Diseases of the circulatory (Cardiovascular) system RC666-701 Hans-Peter Brunner-La Rocca Sandra Sanders-van Wijk Natriuretic Peptides in Chronic Heart Failure
description	Normal brain natriuretic peptide (BNP) and N-terminal proBNP (NT-proBNP) levels are helpful in excluding chronic heart failure in the ambulatory setting, although they have been studied less well and possibly less accurately than in acute care. They may also be of help in screening patients at risk to intervene and reduce the development of heart failure. Natriuretic peptides are also excellent prognostic markers of chronic heart failure, but the clinical value of such prognostic information is less clear. One possible application for this information is guiding medical therapy in chronic heart failure. Many studies have investigated this approach, but results are mixed and do not clearly show improvement in outcome. Still, it may be that in patients with reduced ejection fraction and few comorbidities, measuring NT-proBNP to uptitrate medication improves prognosis.
format	article
author	Hans-Peter Brunner-La Rocca Sandra Sanders-van Wijk
author_facet	Hans-Peter Brunner-La Rocca Sandra Sanders-van Wijk
author_sort	Hans-Peter Brunner-La Rocca
title	Natriuretic Peptides in Chronic Heart Failure
title_short	Natriuretic Peptides in Chronic Heart Failure
title_full	Natriuretic Peptides in Chronic Heart Failure
title_fullStr	Natriuretic Peptides in Chronic Heart Failure
title_full_unstemmed	Natriuretic Peptides in Chronic Heart Failure
title_sort	natriuretic peptides in chronic heart failure
publisher	Radcliffe Medical Media
publishDate	2019
url	https://doaj.org/article/57768560db9c46f5a594691b34c910ef
work_keys_str_mv	AT hanspeterbrunnerlarocca natriureticpeptidesinchronicheartfailure AT sandrasandersvanwijk natriureticpeptidesinchronicheartfailure
_version_	1718372795161772032

Natriuretic Peptides in Chronic Heart Failure

Ejemplares similares